Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical […]
TSX News -
Dominion Lending Centres Inc. Announces New President of Mortgage Architects
VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased […]
Textainer Announces Shareholder Approval of Its Pending Acquisition by Stonepeak and Receipt of Required Antitrust Approvals
HAMILTON, Bermuda and NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) — Textainer Group Holdings Limited (NYSE: TGH; JSE: TXT) (“Textainer”), […]
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will […]
Brixton Metals Receives Typhoon™ Results and Additional Assays from the Hog Heaven Project, Montana
VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) […]
Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
For the first time, patients with alcohol use disorder will receive the company’s unique and proprietary psychedelic – MEAI Vancouver, […]
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the […]
Mikra PROTECT Immune Support Gummy Now Shipping
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), […]
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1 With […]
TSX News -
Onex Reports Fourth Quarter and Full Year 2023 Results
All amounts in U.S. dollars unless otherwise stated TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today […]
